Synthesis, characterization and antibacterial activity of some triazole Mannich bases carrying diphenylsulfone moieties

European Journal of Medicinal Chemistry

Volumn 44, Issue 7, 2009, Pages 3083-3089

  Almajan, Gabriela Laura ^a   Barbuceanu, Stefania Felicia ^a   Almajan, Eva Ruxandra ^b   Draghici, Constantin ^c   Saramet, Gabriel ^a  

^a CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b HORIA HULUBEI NATIONAL INSTITUTE OF PHYSICS AND NUCLEAR ENGINEERING   (Romania)

^c INSTITUTE OF ORGANIC CHEMISTRY   (Romania)

Author keywords

(Phenylsulfonyl)phenyl moiety; 4 Substituted 1,2,4 triazole 3 thiones; Antibacterial activity; Mannich bases

Indexed keywords

4 AMINO 5 [4 (4 PHENYLSULFONYL)PHENYL] 2,4 DIHYDRO 3H 1,2,4 TRIAZOLE 3 THIONE; 4 ARYLIDENEAMINO 5 [4 (4 PHENYLSULFONYL)PHENYL] 2 (MORPHOLIN 4 YLMETHYL) 2,4 DIHYDRO 3H 1,2,4 TRIAZOLE 3 THIONE; 5 [4 (4 PHENYLSULFONYL)PHENYL] 4 PROPYL 2,4 DIHYDRO 3H 1,2,4 TRIAZOLE 3 THIONE; ANTIINFECTIVE AGENT; DIPHENYLSULFONE DERIVATIVE; MANNICH BASE; SULFONE DERIVATIVE; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ARTICLE; BACILLUS SUBTILIS; BACTERIAL STRAIN; CITROBACTER FREUNDII; CONTROLLED STUDY; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENTEROCOCCUS FAECALIS; INFRARED RADIATION; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; SUBSTITUTION REACTION;

ANTI-BACTERIAL AGENTS; BACTERIA; MANNICH BASES; MICROBIAL SENSITIVITY TESTS; SULFONES; TRIAZOLES;

EID: 67349149026     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2008.07.003     Document Type: Article

References (24)

1. Malbec F., Milcent R., Vicart P., and Bure A.M. J. Heterocycl. Chem. 21 (1984) 1769-1774
2. El-Masry A.H., Fahmy H.H., and Ali Abdelwahed S.H. Molecules 5 (2000) 1429-1438
3. Shaker R.N., Mahmoud A.F., and Abdel-Latif F.F. Phosphorus, Sulfur Silicon Relat. Elem. 180 (2005) 397-406
4. Salgi{dotless}n-Gökşen U., Gökhan-Kelekçi N., Göktaş O., Köysal Y., Ki{dotless}li{dotless}ç E., Işi{dotless}k S., Aktayb G., and Özalpd M. Bioorg. Med. Chem. 15 (2005) 5738-5751
5. Garoufalias S.S.P., Todoulou O.G., Filippatos E.C., Valiraki A.E.P., and Chytirogiou-Lada A. Arzeim. Forsch./Drug Res. 48 (1998) 1019-1023
6. Sadana K.A., Mirza Y., Aneja K.R., and Prakash O. Eur. J. Med. Chem. 38 (2003) 533-536
7. Mullican M.D., Wilson M.W., Connor D.T., Kostlan C.R., Schrier D.J., and Dyer R.D. J. Med. Chem. 36 (1993) 1090-1099
8. Holla B.S., Veerendra B., Shivananda M.K., and Poojary B. Eur. J. Med. Chem. 23 (2003) 759-767
9. Karthikeyan M.S., Prasad D.J., Poojary B., Bhat K.S., Holla B.S., and Kumari N.S. Bioorg. Med. Chem. 14 (2006) 7482-7489
10. Tramontini M., and Angiolini L. Tetrahedron 46 (1990) 1791-1837
11. Ashok M., Holla B.S., and Poojary B. Eur. J. Med. Chem. 42 (2007) 1095-1101
12. Holla B.S., Poojary K.N., Sooryanarayana Rao B., and Shivananda M.K. Eur. J. Med. Chem. 37 (2002) 511-517
13. Walczak K., Gondela A., and Suwiński J. Eur. J. Med. Chem. 39 (2004) 849-853
14. Amir M., and Shikha K. Eur. J. Med. Chem. 39 (2004) 535-545
15. Mavrodin A., Zotta V., Stoenescu V.M., and Oteleanu D. Pharm. Zentralhalle Dtschl. 95 (1956) 353-361
16. Elslager E.F., Gavrilis Z.B., Phillips A.A., and Worth D.F. J. Med. Chem. 12 (1969) 357-363
17. Almajan G.L., Barbuceanu S.F., Innocenti A., Scozzafava A., and Supuran C.T. J. Enzyme Inhib. Med. Chem. 23 (2008) 101-107
18. Barbuceanu S.F., Almajan G.L., Saramet I., and Draghici B. Rev. Chim. (Bucharest) 58 (2007) 945-947
19. Barbuceanu S.F., Almajan G.L., Saramet I., and Draghici C. Rev. Chim. (Bucharest) 57 (2006) 355-360
20. Saramet I., Almajan G.L., Barbuceanu S.F., Draghici C., and Banciu M.D. Rev. Roum. Chim. 50 (2005) 19-27
21. Almajan G.L., Barbuceanu S.F., Saramet I., and Draghici C. Rev. Chim. (Bucharest) 56 (2005) 1182-1187
22. Barry A. Procedures and Theoretical Considerations for Testing Antimicrobial Agents in Agar Media. In: Lorian (Ed). Antibiotics in Laboratory Medicine. fifth ed. (1991), Williams and Wilkins, Baltimore
23. National Committee for Clinical Laboratory Standard NCCLS: Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria; Approved Guideline, Document M45-A, vol. 26(19) Willanova PA, USA, 1999.
24. Ghannoum M.A., Eweiss N.F., Bahajaj A.A., and Qureshi M.A. Microbios 37 (1983) 151-157